False
January 2018
Our first issue in 2018 covers the promise of computational pathology in the first of a two-part feature – three gurus explain how it can help enhance pathologists’ work. We also look into chimerism overcoming transplant rejection, the critical importance of inter-departmental teamwork, and how the WHO’s Blue Books evolve to keep up with the changing classifications of cancer. Plus, we sit down with Richard J. Ablin, the man behind the discovery of prostate specific antigen (PSA).
Making a Difference with Microdeletions
January 19, 2018
Testing for the smallest of genetic alterations in childhood leukemias could lead to more accurate prognosis, better treatment decisions, and a higher survival rate
1 min read
A Stromal Solution
January 19, 2018
The tumor-stroma ratio (TSR) could yield more accurate cancer prognoses and improve personalized treatment. The international multicenter UNITED study began in January 2018 to investigate the promise of TSR – so why not join the study?
1 min read
An Answer Out of Time
January 19, 2018
Ancient enzymes – the ancestors to all modern reverse transcriptases – may hold the key to better RNA-based liquid biopsy
1 min read
Acid Test
January 19, 2018
New dipstick technology can extract DNA and RNA from living organisms quickly, efficiently, and without the need for laboratory equipment
1 min read
Onward and Upward for the Blue Books
January 19, 2018
As the nature of cancer classification evolves, the WHO’s Classification of Tumors series turns to evidence-based medicine to fill the gaps in our understanding
1 min read
Traded for a Microscope!
January 19, 2018
Sitting Down With... Richard J. Ablin, Professor of Pathology, University of Arizona College of Medicine, Arizona Cancer Center, BIO5 Institute; and President, Robert Benjamin Ablin Foundation for Cancer Research, Tucson, USA
1 min read
Collaboration Through Communication
January 19, 2018
How we fostered effective communication between pathology professionals and our partners on the healthcare team
1 min read
Can’t Stop the Signal
January 18, 2018
A better understanding of the PARP1 signaling network could lead to improved treatment decision-making in numerous cancers
1 min read
Explore More in Pathology
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
